Capital Fund Management (CFM)’s Integra LifeSciences IART Stock Holding History

Capital Fund Management (CFM)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,322	Closed	-$535K	–	2496
2025 Q3	$535K	Buy	37,322 +1,997	+6%	+$27.4K	﹤0.01%	2286
2025 Q2	$433K	Buy	+35,325	New	+$513K	﹤0.01%	2223
2024 Q4	–	Sell	-41,442	Closed	-$753K	–	2124
2024 Q3	$753K	Buy	+41,442	New	+$961K	﹤0.01%	1763
2023 Q3	–	Sell	-39,548	Closed	-$1.63M	–	2000
2023 Q2	$1.63M	Buy	+39,548	New	+$1.9M	0.01%	1264
2017 Q2	–	Sell	-12,500	Closed	-$527K	–	1576
2017 Q1	$527K	Buy	+12,500	New	+$534K	﹤0.01%	1124

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Capital Fund Management (CFM)'s IART Position: Q4 2025 in Review

Capital Fund Management (CFM) sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 37,322 shares — an estimated $535K sold.

Capital Fund Management (CFM) first reported a position in IART in Q1 2017 and held it in 5 quarters. The position peaked at $1.63M in Q2 2023. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

Capital Fund Management (CFM) reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
Capital Fund Management (CFM) sold 37,322 Integra LifeSciences shares in Q4 2025, an estimated $535K.
Capital Fund Management (CFM) first reported a position in Integra LifeSciences in Q1 2017 and held it in 5 quarters.
Capital Fund Management (CFM)'s Integra LifeSciences position peaked at $1.63M in Q2 2023.
204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2025, filed 17 Feb 2026.